ATGE
Adtalem Global Education Inc.100.32
+2.56+2.62%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q2 '26
Reaffirms Chamberlain rebound, Sallie Mae update
Q&A largely reaffirmed prepared remarks on Walden's balanced growth across behavioral sciences, nursing, and education programs, while fleshing out Chamberlain's rebound path. Management highlighted personnel changes alongside marketing and funnel fixes, expressing confidence in positive year-over-year total enrollment by fiscal year-end via the critical fall cycle. They updated progress on the Sallie Mae partnership for impending July loan cap changes, with definitive docs and a capital syndicate in works—most vital for MedVet. H2 guide upside would stem from quicker Chamberlain recovery and MedVet acceleration. Q&A added color, skipped fireworks. Watch fall enrollment proof.
Key Stats
Market Cap
3.64BP/E (TTM)
15.34Basic EPS (TTM)
6.54Dividend Yield
0%Recent Filings
8-K
Covista refinances $510M debt
Covista refinanced its debt on March 2, 2026, via Amendment No. 5 to its Credit Agreement, issuing $510 million in 2026 Term Loans maturing March 2, 2033, at Term SOFR plus 2.25% (0.75% floor)—a 0.50% margin cut. Proceeds fully retired ~$405 million 5.50% Senior Secured Notes due 2028. Cheaper debt locks in longer terms.
8-K
Covista launches growth strategy
Covista unveiled Purpose at Scale, its FY27-29 strategy targeting 6-11% annual revenue growth and 9-16% adjusted EPS growth amid healthcare shortages. It reaffirmed FY26 guidance of $1,900-1,940M revenue and $7.80-8.00 adjusted EPS, while announcing GE Healthcare AI and rural health partnerships. Enrollment hit 97,000 students. Forward-looking targets carry execution risks.
8-K
Covista rebrands, unveils workforce research
Covista Inc., formerly Adtalem Global Education, completed its name change on February 5, 2026, via Delaware filings, with stock trading as CVSA on NYSE starting February 24. It released the Covista Care Capacity Monitor, documenting U.S. healthcare shortages like 702,000 monthly vacancies outpacing 306,000 unemployed workers, while launching Covista Open Doors for workforce support. Investor Day on February 24 previews strategy. Name fits the pivot.
8-K
Q2 revenue up 12.4%
Adtalem reported Q2 FY2026 revenue of $503.4M, up 12.4% YoY, with total enrollment hitting 97,010 students—up 6.3%—fueled by Walden's 13.0% surge. Adjusted EPS jumped 34.3% to $2.43; they raised full-year guidance to $7.80-$8.00. Enrollment grows steadily. New $750M buyback through 2028 signals confidence, net leverage at 0.9x.
10-Q
Q2 FY2026 results
Adtalem's Q2 revenue jumped 12% y/y to $503M, with Walden up 27%, Chamberlain 2%, and Medical/Vet 7%; operating income rose 7% y/y to $111M while gross margins held at 59% despite restructuring. Diluted EPS climbed 7% y/y to $2.11 on 36M shares, matching reported net income of $76M. Operating cash flow hit $160M YTD, funding $173M buybacks and $50M Term Loan B paydown to $103M principal ($405M Notes due 2028); $500M revolver fully available, cash at $56M. Walden drives the surge. Regulatory scrutiny lingers on Title IV eligibility.
IPO
Website
Employees
Sector
Industry
AACG
ATA Creativity Global
0.91+0.03
APEI
American Public Education, Inc.
37.55-0.08
ASPU
Aspen Group Inc.
0.21+0.06
GV
Visionary Holdings Inc.
1.38-0.02
LAUR
Laureate Education, Inc.
33.56+0.86
LGCY
Legacy Education Inc.
9.77-0.39
LOPE
Grand Canyon Education, Inc.
165.23+3.87
PRDO
Perdoceo Education Corporation
29.49+0.42
STRA
Strategic Education, Inc.
80.96+0.55
TAL
TAL Education Group
11.16-0.07